Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs LTC Properties Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while LTC Properties Inc trades at $42.53 (market cap $2.27B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 5.5× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.42% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and LTC Properties Inc for 88 Days on average.
| HALO | LTC | |
|---|---|---|
Market Cap | $12.58B | $2.27B |
Volume | 2,179,278 | 574,171 |
Sector | Health | Real Estate |
52-Week High | $115.22 | $43.50 |
52-Week Low | $61.63 | $33.98 |
Typical Hold Time | 1 Days | 88 Days |
Enterprise Value | $14.49B | $3.01B |
Dividend Yield | — | 5.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LTC Properties trades at $42.63, up 1.96% today, with mixed technical signals showing bearish overall momentum but bullish moving averages. The REIT maintains strong fundamentals with 38.93% net margins and consistent dividend payments of $0.19 monthly. Recent acquisitions totaling $160 million signal aggressive growth in seniors housing properties, though the stock faces resistance near $43.
Outlook remains cautiously optimistic with a $49.67 analyst price target suggesting 16% upside potential. Key opportunities include demographic tailwinds in senior care and portfolio transformation, while risks involve rising interest rates and execution challenges in SHOP segment expansion. The 31.82% buy rating reflects balanced Wall Street sentiment amid transition phase.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
